ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 789

$1.18M Total Retail Price of All Prescriptions

Rank: 54 out of 789

549 Patients Receiving at Least One Drug in Part D
59% Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,181 673 156 S3 1 2
LEVOTHYROXINE SODIUM 837 556 114 2 1
LISINOPRIL 790 532 132 3 3
OMEPRAZOLE 662 391 100 4 6
FUROSEMIDE 560 416 74 5 7
METFORMIN HCL 511 306 75 6 9
POTASSIUM CHLORIDE 504 366 63 7 16
PRAVASTATIN SODIUM 439 254 64 8 13
ZOLPIDEM TARTRATE 401 174 66 9 29
AMLODIPINE BESYLATE 355 263 58 10 4
GABAPENTIN 354 154 57 11 12
CLOPIDOGREL 352 260 48 12 19
SIMVASTATIN 352 225 56 12 5
METOPROLOL TARTRATE 336 201 66 14 11
POLYETHYLENE GLYCOL 3350 275 208 48 15 56
HYDROCHLOROTHIAZIDE 275 209 43 15 14
TRAMADOL HCL 274 124 58 17 20
LANTUS 274 194 27 17 49
ATORVASTATIN CALCIUM 270 194 49 19 8
NEXIUM 253 83 32 20 34
AMITRIPTYLINE HCL 239 139 39 R 21 81
NAMENDA 232 232 17 22 25
MORPHINE SULFATE ER 219 65 23 S2 23 119
SERTRALINE HCL 213 132 34 24 23
WARFARIN SODIUM 212 168 32 25 10
CITALOPRAM HBR 207 160 31 26 24
DONEPEZIL HCL 205 205 30 27 27
ATENOLOL 201 154 28 28 21
CYCLOBENZAPRINE HCL 195 66 38 R 29 69
ALLOPURINOL 192 138 28 30 32
PANTOPRAZOLE SODIUM 179 101 39 31 26
ALPRAZOLAM 176 63 27 B 32 18
LYRICA 173 81 22 33 84
METOPROLOL SUCCINATE 172 121 26 34 15
CYMBALTA 162 76 21 35 30
CARBIDOPA-LEVODOPA 159 137 22 36 106
ISOSORBIDE MONONITRATE ER 157 136 28 37 48
CARVEDILOL 155 98 22 38 22
MONTELUKAST SODIUM 154 73 21 39 51
OXYCODONE HCL-ACETAMINOPHEN 150 65 19 S2 40 86
LEVOFLOXACIN 145 98 85 41 67
BUSPIRONE HCL 139 76 27 42 125
GLIPIZIDE 136 86 20 43 77
CRESTOR 133 78 15 44 31
RISPERIDONE 132 72 18 A 45 78
LORAZEPAM 130 125* 21 B 46 42
RANITIDINE HCL 128 96 24 47 58
PAROXETINE HCL 128 41 20 47 70
VENLAFAXINE HCL ER 127 45 16 49 89
FLUTICASONE PROPIONATE 125 72 37 50 43
FENTANYL 119 59 13 S2 51 75
CLONAZEPAM 118 17 14 B 52 57
ESCITALOPRAM OXALATE 116 55 24 53 38
CLONIDINE HCL 112 67 17 54 63
GLIPIZIDE ER 107 82 14 55 108
MELOXICAM 101 52 14 56 37
MIRTAZAPINE 100 64 19 57 52
PIOGLITAZONE HCL 98 76 12 R 58 109
NABUMETONE 96 49 15 59 179
OXYCONTIN 95 <11 <11 S2 60 163
PROAIR HFA 95 28 24 60 44
PROPRANOLOL HCL 95 37 13 60 127
BUMETANIDE 94 73 21 63 135
PROMETHAZINE HCL 93 24 29 R 64 123
BACLOFEN 92 49 11 65 126
NITROFURANTOIN MONO-MACRO 92 87* 35 65 176
ZETIA 89 <11 <11 67 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 55 18 68 36
ALENDRONATE SODIUM 88 70 14 68 35
KLOR-CON M20 88 48 18 68 50
GEMFIBROZIL 88 38 15 68 121
TAMSULOSIN HCL 85 51 15 72 28
HYDROXYZINE PAMOATE 84 16 13 R 73 343
SUCRALFATE 82 59 16 74 193
HUMALOG 80 42 14 75 91
METOCLOPRAMIDE HCL 79 18 18 76 150
SPIRONOLACTONE 77 35 12 77 59
ADVAIR DISKUS 75 55 14 78 55
ROPINIROLE HCL 74 58 12 79 72
LEVEMIR 74 <11 <11 79 141
NOVOLOG 74 69* 11 79 92
QUETIAPINE FUMARATE 73 48 12 A 82 68
PREDNISONE 72 53 27 83 40
ESTRADIOL 72 <11 <11 R 83 198
DILTIAZEM 24HR ER 70 <11 <11 85 103
IBUPROFEN 70 14 16 85 122
OXYCODONE HCL 70 <11 <11 S2 85 115
DIVALPROEX SODIUM 69 49 15 88 80
PHENYTOIN SODIUM EXTENDED 67 <11 <11 89 156
OXYBUTYNIN CHLORIDE ER 66 <11 <11 90 110
DIVALPROEX SODIUM ER 65 30 14 91 174
TRAZODONE HCL 64 <11 <11 92 41
ABILIFY 64 <11 <11 A 92 134
LEVETIRACETAM 64 <11 <11 92 97
JANUVIA 61 <11 <11 95 66
DIOVAN 60 <11 <11 96 53
COLCRYS 59 54* 12 97 206
CHLORZOXAZONE 58 <11 17 R 98 428
SYMBICORT 58 <11 <11 98 136
FAMOTIDINE* 58 <11 <11 98 60
OXYBUTYNIN CHLORIDE 57 <11 <11 101 101
GLIMEPIRIDE 56 <11 <11 102 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 41 33 102 95
LIDODERM 55 34 13 104 149
DIGOX 55 <11 <11 104 98
HYDRALAZINE HCL 54 <11 <11 106 74
FLUOXETINE HCL 52 <11 <11 107 45
OXYCODONE-ACETAMINOPHEN 52 <11 <11 S2 107 85
METHADONE HCL 52 <11 <11 S2 107 218
AZITHROMYCIN 51 46* 35 110 54
NYSTATIN 51 39 21 110 105
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.